1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid [11C]methyl ester
- PMID: 20641333
- Bookshelf ID: NBK23130
1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid [11C]methyl ester
Excerpt
In the adrenocortex, 11β-hydroxylase is a key enzyme in the biosynthesis of cortisol and aldosterone. This enzyme can be overexpressed in adrenocortical carcinomas, which secrete excessive amounts of catecholamines and cortical hormone (1). However, some adrenal tumors appear unexpectedly as incidentalomas in computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound scans in 1-4% of patients (2). Most of these incidentalomas consist of benign, cortical, nonhypersecretory adenomas (3). Therefore, it is important to identify the malignant lesions in the incidentalomas for appropriate clinical treatments. Ketoconazole, etomidate and metomidate are potent inhibitors of 11β-hydroxylase (4, 5). [11C]Metomidate introduced as an adrenocortical imaging tracer by Bergstrom et al. (6) has proven to be useful in distinguishing adrenocortical from non-cortical lesions and identifying incidentalomas of adrenocortical origin (7-10).
Sections
Similar articles
-
Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas.Eur J Radiol. 2009 Feb;69(2):314-23. doi: 10.1016/j.ejrad.2007.10.024. Epub 2007 Dec 20. Eur J Radiol. 2009. PMID: 18082990
-
Positron emission tomography imaging of adrenal masses: (18)F-fluorodeoxyglucose and the 11beta-hydroxylase tracer (11)C-metomidate.Eur J Nucl Med Mol Imaging. 2004 Sep;31(9):1224-30. doi: 10.1007/s00259-004-1575-0. Epub 2004 Jun 10. Eur J Nucl Med Mol Imaging. 2004. PMID: 15197504 Clinical Trial.
-
In vitro and in vivo primate evaluation of carbon-11-etomidate and carbon-11-metomidate as potential tracers for PET imaging of the adrenal cortex and its tumors.J Nucl Med. 1998 Jun;39(6):982-9. J Nucl Med. 1998. PMID: 9627330
-
11C-metomidate PET in the diagnosis of adrenal masses and primary aldosteronism: a review of the literature.Endocrine. 2020 Dec;70(3):479-487. doi: 10.1007/s12020-020-02474-3. Epub 2020 Sep 4. Endocrine. 2020. PMID: 32886316 Review.
-
The role of PET in localization of neuroendocrine and adrenocortical tumors.Ann N Y Acad Sci. 2002 Sep;970:159-69. doi: 10.1111/j.1749-6632.2002.tb04422.x. Ann N Y Acad Sci. 2002. PMID: 12381551 Review.
References
-
- Suzuki H., Shibata H., Maruyama T., Ishimura Y., Saruta T. Significance of steroidogenic enzymes in the pathogenesis of hyperfunctioning and non-hyperfunctioning adrenal tumor. . Steroids. 1995;60(1):42–7. - PubMed
-
- Bertherat J., Mosnier-Pudar H., Bertagna X. Adrenal incidentalomas. . Curr Opin Oncol. 2002;14(1):58–63. - PubMed
-
- Kloos R.T., Gross M.D., Francis I.R., Korobkin M., Shapiro B. Incidentally discovered adrenal masses. . Endocr Rev. 1995;16(4):460–84. - PubMed
-
- Engelhardt D. Steroid biosynthesis inhibitors in Cushing's syndrome. . Clin Investig. 1994;72(7):481–8. - PubMed
-
- Varga I., Racz K., Kiss R., Futo L., Toth M., Sergev O., Glaz E. Direct inhibitory effect of etomidate on corticosteroid secretion in human pathologic adrenocortical cells. . Steroids. 1993;58(2):64–8. - PubMed
Publication types
LinkOut - more resources
Full Text Sources